Published reports collectively suggest that CXCL8 can recruit tumor-associated macrophages (TAMs), myeloid derived suppressor cells (MDSCs), and neutrophils to the TME, resulting in dampening the anti-tumor immune response of cytotoxic immune cells. The gene discussed is CXCL8; the disease is neoplasm.